Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection

By Y. Jeong, B. Kim. 2003

6,031 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I (2005, background): “HCV infection is treated with alpha interferon (IFN- )based therapy, but treatment is effective at best in only 50% of patients (10).”
Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. (2005, background): “Mean (SD) bilirubin, mol/L 12 (8) 12 (5) 0.”
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. (2013, unknown): “Nonresponse 2 (3) 2 (1) 25 (24) 25 (26)”
Boceprevir for Untreated Chronic HCV Genotype 1 Infection (2011, unknown): “Missing data 13 (4) 10 (3) 10 (3) 2 (4) 0 2 (4) 15 (4) 10 (3) 12 (3)”
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. (2004, background): “HCV infection Estimated duration of infection, median (range), y 16 (2-30) 17 (3-33) .”